There is a worldwide concern about the new coronavirus 2019-nCoV as a global public health threat. In this article, we provide a preliminary evolutionary and molecular epidemiological analysis of this new virus. A phylogenetic tree has been built using the 15 available whole genome sequences of 2019-nCoV, 12 whole genome sequences of 2019-nCoV, and 12 highly similar whole genome sequences available in gene bank (five from the severe acute respiratory syndrome, two from Middle East respiratory syndrome, and five from bat SARS-like coronavirus). Fast unconstrained Bayesian approximation analysis shows that the nucleocapsid and the spike glycoprotein have some sites under positive pressure, whereas homology modeling revealed some molecular and structural differences between the viruses.
The phylogenetic tree showed that 2019-nCoV significantly clustered with bat SARSlike coronavirus sequence isolated in 2015, whereas structural analysis revealed mutation in Spike Glycoprotein and nucleocapsid protein. From these results, the new 2019-nCoV is distinct from SARS virus, probably trasmitted from bats after mutation conferring ability to infect humans. The family Coronaviridae comprises a group of large, single, plusstranded RNA viruses isolated from several species, and it is previously known to cause the common cold and diarrheal illnesses in humans. 1, 2 6, 7 Animal to human transmission is considered the origin of epidemics, as many patients declared to have visited a local fish and wild animal market in Wuhan in November. Quite recently, evidence has been gathered for the animal to the human and interhuman transmission of the virus. 7, 8 Although prompt diagnosis and patient isolation are the hallmarks for initial control of this new epidemic, molecular epidemiology, evolutionary models, and phylogenetic analysis can help estimate genetic variability and the evolutionary rate, which in turn have important implications for disease progression as Silvia Angeletti and Massimo Ciccozzi contributed equally to this study. well as for drug and vaccine development. In this short report, we provide a phylogenetic tree of the 2019-nCoV and identify sites of positive or negative selection pressure in distinct regions of the virus.
| MATERIAL AND METHODS
The complete genomes of 15 2019-nCoV sequences have been downloaded from GISAID (https://www.gisaid.org/) and GenBank (http://www.ncbi.nlm.nih.gov/genbank/). A dataset has been built using five highly similar sequences for SARS, two sequences for the Middle East respiratory syndrome (MERS), and five highly similar sequences for bat SARS-like coronavirus. The percentage of similarity has been identified using a basic local alignment search tool (https:// blast.ncbi.nlm.nih.gov/Blast.cgi); eventually duplicated sequences have been excluded from the datasets. The dataset including 27 sequences has been aligned using multiple sequence alignment online tool 9 and manually edited using BioEdit program v7.0.5. 10 Maximum likelihood (ML) methods were employed for the analyses because they allow for testing different phylogenetic hypotheses by calculating the probability of a given model of evolution generating the observed data and by comparing the probabilities of nested models by the likelihood ratio test. The best-fitting nucleotide substitution model was chosen by jModeltest software. 11 ML tree was reconstructed using generalized time-reversible plus gamma distribution and invariant sites (+G+I) as an evolutionary model using MEGA-X. 12 The adaptive evolution server (http://www.datamonkey.org/) was used to find eventual sites of positive or negative selection. For this purpose, the following test has been used: fast unconstrained Bayesian approximation (FUBAR). 13 This test allowed us to infer the site-specific pervasive selection, the episodic diversifying selection across the region of interest, and to identify episodic selection at individual sites. 14 The statistically significant positive or negative selection was based on P value less than .05. 14 
Homology models have been built relying on the website
SwissModel. 15 Structural templates have been searched and validated using the software available within the SwissModel environment and HHPred. 16 Homology models have been validated using the QMEAN tool. 17 Three-dimensional structures have been analyzed and displayed using PyMOL. 18 To map the structural variability of the N, E, S, and M regions of the virus and their sites under selection pressure, homology modeling has been applied to the sequence of 2019-nCoV.
| RESULTS
The ML phylogenetic tree, performed on whole genome sequences, is represented in Figure 1 In particular, in this case, the 2019-nCoV has a polar amino acid, whereas the SARS has a nonpolar amino acid (Figure 2 ).
Regarding the sites under positive selective pressure found on the spike glycoprotein, the results have shown that the 536th aminoacidic position in 2019-nCoV has an asparagine residue, whereas the bat SARS-like coronavirus has a glutamine residue. The SARS virus, instead, has an aspartic acid residue. On the 644th aminoacidic position in 2019-nCoV sequence, there is a threonine residue, whereas the bat SARS-like virus has a serine residue. The SARS virus, however, has an alanine residue. is more similar to Bungarus multicinctus snake compared with other animals and humans. In a previous article, it has been proven that compositional properties, mutation pressure, natural selection, gene expression, and dinucleotides, affect the codon usage bias of Bungarus species. 19 These data, along with analysis from our study, enforcing bat origin of infection, could clarify the transmission dynamics of the 2019-nCoV, supporting infection control policy during the ongoing epidemic.
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